Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Stomach”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04933227
What this trial is testing

Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ)

Who this might be right for
Stomach NeoplasmsGastric CancerGastroesophageal Junction Adenocarcinoma
Hoffmann-La Roche 29
Large-scale testing (Phase 3)Active Not RecruitingNCT05002127
What this trial is testing

Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)

Who this might be right for
Gastric CancerGastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
ALX Oncology Inc. 127
Testing effectiveness (Phase 2)Study completedNCT01336062
What this trial is testing

Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients

Who this might be right for
Gastric Adenocarcinoma
Peking University 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Looking for participantsNCT04982276
What this trial is testing

AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
Akeso 138
Testing effectiveness (Phase 2)Ended earlyNCT05687617
What this trial is testing

Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.

Who this might be right for
Gastric CancerGastric AdenocarcinomaPeritoneal Carcinomatosis+1 more
Laval University 11
Testing effectiveness (Phase 2)Study completedNCT00011960
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery

Who this might be right for
Esophageal CancerGastric Cancer
Radiation Therapy Oncology Group
Not applicableUnknownNCT05185791
What this trial is testing

ERAS® Guidelines Validation of CRS With or Without HIPEC

Who this might be right for
Peritoneal Diseases
Hospices Civils de Lyon 288
Testing effectiveness (Phase 2)UnknownNCT05122091
What this trial is testing

Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma

Who this might be right for
Gastric CancerGastroEsophageal CancerFruquintinib+1 more
Guangxi Medical University 53
Very early researchLooking for participantsNCT06937567
What this trial is testing

CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors

Who this might be right for
Biliary Tract CancerColorectal CarcinomaGastric Cancer, Metastatic+2 more
Zhejiang University 36
Not applicableStudy completedNCT07781319
What this trial is testing

Early Gastric Cancer in the Spanish EURECCA Registry

Who this might be right for
Early Gastric CancerGastric Adenocarcinoma
Corporacion Parc Tauli 600
Testing effectiveness (Phase 2)Looking for participantsNCT07102901
What this trial is testing

Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma

Who this might be right for
Advanced Gastric CancerMetastatic Gastric CancerGastroesophageal Junction Adenocarcinoma
Jiangsu HengRui Medicine Co., Ltd. 351
Not applicableLooking for participantsNCT07607119
What this trial is testing

PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaStomach NeoplasmsLocally Advanced Gastric Cancer+1 more
Samsung Medical Center 53
Not applicableStudy completedNCT03158571
What this trial is testing

Chilean Gastric Cancer Task Force (FORCE 1)

Who this might be right for
Biomarkers
Pontificia Universidad Catolica de Chile 116
Testing effectiveness (Phase 2)Study completedNCT00869050
What this trial is testing

Capecitabine and Temozolomide for Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Tumors
Columbia University 41
Large-scale testing (Phase 3)UnknownNCT02289547
What this trial is testing

Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
The Catholic University of Korea 184
Testing effectiveness (Phase 2)Looking for participantsNCT05482893
What this trial is testing

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaPancreatic Ductal AdenocarcinomaBiliary Tract Cancer (BTC)
Phanes Therapeutics 258
Not applicableUnknownNCT03051152
What this trial is testing

D1 Versus D2 Lymphadenectomy in High Risk Elderly With Gastric Adenocarcinoma

Who this might be right for
Gastric CancerLocally Advanced Malignant NeoplasmPerioperative/Postoperative Complications
Italian Research Group for Gastric Cancer 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06939452
What this trial is testing

A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression

Who this might be right for
Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Yongxu Jia 37
Not applicableEnrolling By InvitationNCT07708012
What this trial is testing

Clinical Study on Using Laparoscopic Sentinel Lymph Node Navigation Combined With Dual Endoscopy Surgery for Early Gastric Cancer

Who this might be right for
Early-stage Upper Gastrointestinal CancerStomach Cancer, AdenocarcinomaLaparoscopy-assisted Surgery+1 more
wangdongsheng 30
Next Page